Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Saudi Arabia Pancreatic Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... Arabia market. Moreover, the report provides deep insights intdemand forecasts, market trends, and, micrand macrindicators in the Saudi Arabia market. Also, factors that are driving and restraining the pancreatic cancer market are highlighted in the ... Read More
-
Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends
... be estimated based on treatment type, route of administration, end use, distribution channel and region. Report Includes: 42 data tables and 57 additional tables An overview of the global market for acute myeloid leukemia (AML) ... Read More
-
Germany Cancer Monoclonal Antibody Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... market. Moreover, the report provides deep insights intdemand forecasts, market trends, and, micrand macrindicators in the Germany market. Also, factors that are driving and restraining the cancer monoclonal antibody market are highlighted in the study. ... Read More
-
South Korea Pancreatic Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... Korea market. Moreover, the report provides deep insights intdemand forecasts, market trends, and, micrand macrindicators in the South Korea market. Also, factors that are driving and restraining the pancreatic cancer market are highlighted in the ... Read More
-
Russia Pancreatic Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the report provides deep insights intdemand forecasts, market trends, and, micrand macrindicators in the Russia market. Also, factors that are driving and restraining the pancreatic cancer market are highlighted in the study. This is an ... Read More
-
United Arab Emirates Pancreatic Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the United Arab Emirates market. Moreover, the report provides deep insights intdemand forecasts, market trends, and, micrand macrindicators in the United Arab Emirates market. Also, factors that are driving and restraining the pancreatic cancer market ... Read More
-
Pancreatic Cancer Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030
... cancer market was valued at USD 2448.9 million in 2022 and is expected treach USD 7114.4 million in 2030, with a CAGR of 12.5% during the forecast period 2023-2030. The study on pancreatic cancer market ... Read More
-
Cancer Monoclonal Antibody Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030
... monoclonal antibody market was valued at around USD 51.2 billion in 2022 and is expected treach USD 93.5 billion in 2030, with a CAGR of 6.8% during the forecast period 2023-2030. The study on cancer ... Read More
-
Africa Pancreatic Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the report provides deep insights intdemand forecasts, market trends, and, micrand macrindicators in the Africa market. Also, factors that are driving and restraining the pancreatic cancer market are highlighted in the study. This is an ... Read More
-
Global Hematological Malignancies Emerging Therapeutics Market 2023
... in 2022 and is expected to reach $23.27 billion by 2029. Pharmaceutical companies' interest in developing therapies for hematological malignancies has driven market advancements. Monoclonal antibodies have been widely used, but there is an anticipated ... Read More
-
Cutaneous Squamous Cell Carcinoma (cSCC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... million diagnosed prevalent cases of DN are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for DN. Among the marketed DN drugs available, most of the drugs are enzyme inhibitors, followed ... Read More
-
US and Europe Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral Vectors and Non-Viral Vectors)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Country
... Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Country The US and Europe cell and gene therapy manufacturing services market was valued at ... Read More
-
Retinoblastoma Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2028, at a CAGR of 4.45% during the forecast period (2023-2028). The COVID-19 pandemic created a significant void in the availability and accessibility of treatment modalities and timely intervention for children with eye cancer. For ... Read More
-
Breast Biopsy Devices Market by Type (Needles, Tables, Assay kits, Liquid Biopsy), Procedure (CNB, FNAB, VAB, Surgical), Technique (Stereotactic, USG, MRI), Application (Screening, Treatment), End User (Hospitals, Clinic) & Region - Global Forecast to 2028
... The global breast biopsy devices market is projected to reach USD 2.6 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 10.0% from 2023 to 2028. The market growth is propelled ... Read More
-
Cancer Biomarkers Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2028, at a CAGR of 12.43% during the forecast period (2023-2028). The COVID-19 pandemic had an adverse impact on the cancer biomarkers market owing to the interrupted research and development activities during this period. For ... Read More
-
Head And Neck Cancer Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023 to USD 8.89 billion by 2028, at a CAGR of 11.62% during the forecast period (2023-2028). The COVID-19 pandemic has affected healthcare systems globally and significantly impacted the head and neck cancer diagnosis market. ... Read More
-
Colorectal Cancer Molecular Diagnostics Industry Research Report 2023
... business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Molecular Diagnostics. The Colorectal Cancer Molecular Diagnostics market size, estimations, and forecasts are ... Read More
-
Europe Biosimilars Market Forecast to 2030 - Regional Analysis By Disease Indication (Cancer, Diabetes, Autoimmune Disease, and Other Disease Indication), Route of Administration (Intravenous, Subcutaneous, and Others), Drug Class (Granulocyte Colony-Stimulating Factor, Insulin, TNF Blockers and Monoclonal Antibodies, and Others), Distribution Channel (Hospital Pharmacies, Compounding Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region
... and Monoclonal Antibodies, and Others), Distribution Channel (Hospital Pharmacies, Compounding Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region The Europe biosimilars market is expected to grow from US$ 10,344.86 million in 2022 to US$ 1,15,125.91 ... Read More
-
Digital Thoracic Drainage Devices Market Forecast to 2030 - Global Analysis by Product Type (Single Chamber and Multiple Chambers), Application (Cardiac Surgeries, Thoracic and Pulmonary Surgery, Oncology and Trauma, Infectious Diseases, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography
... (Hospitals, Ambulatory Surgical Centers, and Others), and Geography The Digital thoracic drainage devices market was valued at US$ 155.34 million in 2022 and is expected to reach US$ 232.29 million by 2030; it is estimated ... Read More
-
HER2-Positive Gastric Cancer
... posed by gastric cancers that overexpress the human epidermal growth factor receptor 2 (HER2) protein. These advancements hold significant promise for improving patient outcomes, transforming the diagnosis, treatment, and prognosis of HER2-positive gastric cancer. The ... Read More
-
PD-1 Resistant Head and Neck Cancer
... on the surface of T cells, which are a type of immune cell that plays a key role in fighting off infections and cancer. The market for PD-1-resistant head and neck cancer is a rapidly ... Read More
-
Checkpoint Inhibitor Refractory Cancer
... cause of morbidity and mortality worldwide. As the global population ages, the incidence of cancer is expected to increase, creating a growing demand for cancer treatments including checkpoint inhibitor refractory cancer market. According to the ... Read More
-
Global Radioimmunotherapy Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
... US$ 4479 million by 2029 with a CAGR of 17.43% during the forecast period 2023-2029. The global key companies of Radioimmunotherapy include Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Curium Pharmaceuticals, and ... Read More
-
Global Oncology Devices Market (2023 Edition): Analysis By Device Type (Ablation, Embolization, Others), Cancer Type (Breast, Uterine, Colon and Rectum, Prostate, Others), By Application, By Region, By Country: Drivers, Trends and Forecast to 2029
... Summary Azoth Analytics has released a research report titled “Oncology Devices Market (2023 Edition)” which provides a complete analysis of the global Oncology Devices By Device Type (Ablation Devices, Embolization devices, Other Devices), Cancer Type ... Read More
-
DNA Synthesis Technologies and Services Market, 2022-2035
... worth highlighting that several research studies are being conducted to evaluate the use of oligonucleotides, especially DNA, as a therapeutic intervention for treatment of various medical conditions. The approval of the first antisense oligonucleotide drug, ... Read More
Research Assistance
